Regenerex Pharma auditor dbbmckennon resigns; going concern doubt noted

REGENEREX PHARMA, INC.

dbbmckennon resigned as independent auditor effective Aug 31, 2026, after serving since 2017.
Auditor reports for FY2025 and transition period included going concern explanatory paragraph.
Transition period report also noted revision for related party transaction disclosures.
No disagreements or reportable events in last two fiscal years; company seeking successor auditor.
Company is behind on outstanding periodic reports and will work with successor to catch up.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.